EXTON, Pa. and LEUSDEN, Netherlands, June 15 /PRNewswire/ -- Acceletronics, Inc., a U.S. provider of Oncology equipment service and distributor of new and pre-owned radiotherapy equipment, today announced that it has sold 6 TheraView Electronic Portal Imaging Devices (EPID) to free standing cancer treatment centers in California, Oregon and Washington. The TheraView EPID is an image guided radiotherapy (IGRT) cancer treatment verification system, designed by Dutch manufacturer Cablon Medical BV. Acceletronics and Cablon have a strategic alliance to market and support the new TheraView Technology line of portal imaging systems. The TheraView® system, designed for the precise needs of radiation therapy, delivers Clinicians an extensive scope of mega-voltage portal imaging and quality assurance features. TheraView Target Check® with automated treatment beam shape verification and patient position verification software gives the precision and control Clinicians need for both conventional, image guided (IGRT) and intensity modulated radiation therapy (IMRT).
